AJOONI Income Statement - TTM - Ajooni Biotech Limited

Income Statement (TTM)

Ajooni Biotech Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	455	466	510	571	633	697	740	705	624	537	745	832	924	1,018	803	848	912	1,051	1,147	1,203
Change (%)		2.47	9.44	11.78	11.01	10.07	6.20	-4.78	-11.49	-13.87	38.60	11.67	11.05	10.20	-21.16	5.63	7.53	15.34	9.09	4.89
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	390	397	430	483	534	597	640	609	537	450	657	743	836	933	703	740	790	898	970	1,002
Change (%)		1.65	8.37	12.26	10.49	11.81	7.31	-4.87	-11.89	-16.17	46.14	12.99	12.61	11.59	-24.63	5.17	6.72	13.75	8.03	3.23
% of Revenue	85.79	85.11	84.27	84.64	84.24	85.57	86.46	86.38	85.99	83.70	88.26	89.30	90.56	91.70	87.66	87.28	86.61	85.42	84.60	83.26

Gross Operating Profit	65	69	80	88	100	101	100	96	87	88	87	89	87	84	99	108	122	153	177	201
Change (%)		7.39	15.59	9.21	13.86	0.80	-0.35	-4.19	-8.98	0.19	-0.15	1.76	-2.01	-3.15	17.27	8.91	13.12	25.61	15.26	14.04
% of Revenue	14.21	14.89	15.73	15.36	15.76	14.43	13.54	13.62	14.01	16.30	11.74	10.70	9.44	8.30	12.34	12.72	13.39	14.58	15.40	16.74

SG&A	32	22	52	12	54	55	56	16	58	59	51	18	52	53	64	18	67	69	28	32
Change (%)		-30.21	131.63	-76.69	349.04	1.75	1.48	-71.00	255.99	1.15	-13.04	-65.16	190.56	1.93	22.47	-71.43	262.48	4.16	-60.25	15.21
% of Revenue	7.04	4.80	10.15	2.12	8.57	7.92	7.57	2.30	9.27	10.89	6.83	2.13	5.58	5.16	8.01	2.17	7.30	6.60	2.40	2.64

R&D
Change (%)
% of Revenue

OpEx	441	455	499	559	618	677	719	685	608	525	725	815	904	1,009	784	831	889	1,013	1,121	1,180
Change (%)		3.05	9.86	11.99	10.41	9.63	6.16	-4.68	-11.33	-13.58	38.09	12.36	10.91	11.62	-22.31	6.08	6.89	13.99	10.67	5.25
% of Revenue	96.94	97.49	97.87	98.05	97.52	97.13	97.09	97.19	97.37	97.71	97.35	97.95	97.83	99.09	97.64	98.06	97.48	96.34	97.74	98.07

Operating Income	14	12	11	11	16	20	22	20	16	12	20	17	20	9	19	16	23	38	26	23
Change (%)		-16.00	-6.94	2.13	41.34	27.30	7.63	-8.08	-17.10	-24.93	60.04	-13.56	17.77	-53.87	104.49	-13.23	39.89	67.40	-32.58	-10.53
% of Revenue	3.06	2.51	2.13	1.95	2.48	2.87	2.91	2.81	2.63	2.29	2.65	2.05	2.17	0.91	2.36	1.94	2.52	3.66	2.26	1.93

Interest Expense	-1	-3		-6	-1	-0		-5				-5	-1	-1		-6			-3	-3
Change (%)		351.27			-76.04	-99.11							-81.93	-4.75						-19.62
% of Revenue	-0.16	-0.71		-1.07	-0.23	-0.00		-0.72				-0.62	-0.10	-0.09		-0.68			-0.29	-0.22

Net Income	7	4	4	4	7	11	10	11	9	5	11	12	15	18	22	22	26	27	34	37
Change (%)		-37.50	-8.82	3.12	69.11	63.59	-1.45	0.81	-18.64	-37.05	107.69	7.10	20.71	22.82	21.03	3.07	18.24	4.15	22.93	9.29
% of Revenue	1.44	0.88	0.73	0.67	1.03	1.53	1.42	1.50	1.38	1.01	1.51	1.45	1.57	1.75	2.69	2.63	2.89	2.61	2.94	3.06

Source: Capital IQ

Ajooni Biotech Limited - Income Statement (TTM)

Income Statement (TTM)